Jaundice, which commonly shows up in infants as the yellowish pigmentation of the skin due to high bilirubin levels in the blood, can be caused by a number of different medical conditions.
Many new or expectant parents are surprised to learn how common jaundice is in newborn babies. According to research in The New England Journal of Medicine, jaundice shows up in approximately 60 percent of all newborn babies within the first week.
In most cases, infants exhibit nonpathological, or physiologic, jaundice that is not connected to any serious medical condition. Nonetheless, if untreated, the rising bilirubin levels may lead to further complications.
Fortunately, this common condition is easy to treat through phototherapy. The process is remarkably simple: specialized light is used to convert the excess bilirubin into water-soluble isomers the infant’s body can excrete.
To be effective, phototherapy needs to employ a specific kind of light that can be absorbed by the infant. One of the most effective treatments available, the BT-400, uses blue-light phototherapy, a far more effective treatment option than either halogen or ultraviolet lights.
The BT-400 is lightweight, compact, has two adjustable levels of intensity and boasts an incredible 20,000 hours of operating time. Because neonatal jaundice is so common, this simple and highly effective instrument has a place in any practice that treats infants or families.